Jing Luo
Yangtze University(CN)Xiangyang Central Hospital(CN)
Publications by Year
Research Areas
Diabetes Management and Research, Pharmaceutical Economics and Policy, Diabetes Treatment and Management, Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical studies and practices
Most-Cited Works
- → Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US(2021)245 cited
- → Cost-Related Insulin Underuse Among Patients With Diabetes(2018)226 cited
- → Coverage, Formulary Restrictions, and Out-of-Pocket Costs for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Medicare Part D Program(2020)93 cited
- → HIV Transmission Risk Among Serodiscordant Couples: A Retrospective Study of Former Plasma Donors in Henan, China(2010)87 cited
- → RETRACTED ARTICLE: The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma(2020)84 cited
- → Chronic Ventromedial Hypothalamic Infusion of Norepinephrine and Serotonin Promotes Insulin Resistance and Glucose Intolerance(1999)63 cited
- → Real‐world weight‐loss effectiveness of glucagon‐like peptide‐1 agonists among patients with type 2 diabetes: A retrospective cohort study(2023)59 cited
- → Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular Disease(2023)59 cited
- → MicroRNA-146a-5p enhances radiosensitivity in hepatocellular carcinoma through replication protein A3-induced activation of the DNA repair pathway(2018)53 cited
- → The Relationship between Restrained Eating, Body Image, and Dietary Intake among University Students in China: A Cross-Sectional Study(2021)53 cited